178 related articles for article (PubMed ID: 30230263)
1. Pharmacokinetics, Excretion, and Mass Balance of [
Ambery C; Young G; Fuller T; Lazaar AL; Pereira A; Hughes A; Ramsay D; van den Berg F; Daley-Yates P
Clin Pharmacol Drug Dev; 2018 Nov; 7(8):901-910. PubMed ID: 30230263
[TBL] [Abstract][Full Text] [Related]
2. Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.
Ambery C; Riddell K; Daley-Yates P
Clin Pharmacol Drug Dev; 2016 Sep; 5(5):399-407. PubMed ID: 27170445
[TBL] [Abstract][Full Text] [Related]
3. Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite.
Bourdet DL; Yeola S; Hegde SS; Colson PJ; Barnes CN; Borin MT
Drug Metab Dispos; 2020 Dec; 48(12):1312-1320. PubMed ID: 32978223
[TBL] [Abstract][Full Text] [Related]
4. Open-Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or Concurrently.
Ambery C; Young G; Fuller T; Georgiou A; Ramsay D; Puri A; Daley-Yates P
Clin Pharmacol Drug Dev; 2019 Feb; 8(2):188-197. PubMed ID: 30070770
[TBL] [Abstract][Full Text] [Related]
5. An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects.
Harrell AW; Wilson R; Man YL; Riddell K; Jarvis E; Young G; Chambers R; Crossman L; Georgiou A; Pereira A; Kenworthy D; Beaumont C; Marotti M; Wilkes D; Hessel EM; Fahy WA
Drug Metab Dispos; 2019 Dec; 47(12):1457-1468. PubMed ID: 31649125
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects.
Holmberg AA; Weidolf L; Necander S; Bold P; Sidhu S; Pelay-Gimeno M; de Ligt RAF; Verheij ER; Jauhiainen A; Psallidas I; Wählby Hamrén U; Prothon S
Drug Metab Dispos; 2022 Feb; 50(2):150-157. PubMed ID: 34853068
[TBL] [Abstract][Full Text] [Related]
7. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
8. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
9. The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [
Burkard U; Desch M; Shatillo Y; Wunderlich G; Mack SR; Schlecker C; Teitelbaum AM; Liu P; Chan TS
Clin Drug Investig; 2022 Jan; 42(1):87-99. PubMed ID: 34936055
[TBL] [Abstract][Full Text] [Related]
10. A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a
Singh RSP; Dowty ME; Salganik M; Brodfuehrer JI; Walker GS; Sharma R; Beebe JS; Danto SI
Clin Pharmacol Drug Dev; 2022 Jul; 11(7):815-825. PubMed ID: 35506501
[TBL] [Abstract][Full Text] [Related]
11. Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
Lindmark B; Li XQ; Bhattacharya C; Housler G; Heijer M; Bragg RA; Gränfors M; Pelay-Gimeno M; Vaes WHJ; Menakuru S; Pizzato PE; Ericsson H; Johansson S
Drug Metab Dispos; 2023 Aug; 51(8):995-1004. PubMed ID: 37407094
[TBL] [Abstract][Full Text] [Related]
12. Use of propranolol blockade to explore the pharmacology of GSK961081, a bi-functional bronchodilator, in healthy volunteers: results from two randomized trials.
Norris V; Ambery C
Drugs R D; 2014 Dec; 14(4):241-51. PubMed ID: 25265895
[TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution, metabolism, and excretion of dirlotapide in the dog.
Merritt DA; Bessire AJ; Vaz AD; Sams JP; Lynch MP
J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():17-23. PubMed ID: 17567511
[TBL] [Abstract][Full Text] [Related]
14. Mass Balance, Metabolism, and Excretion of Cenobamate, a New Antiepileptic Drug, After a Single Oral Administration in Healthy Male Subjects.
Vernillet L; Greene SA; Kim HW; Melnick SM; Glenn K
Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):513-522. PubMed ID: 32301064
[TBL] [Abstract][Full Text] [Related]
15. Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants.
Devineni D; Murphy J; Wang SS; Stieltjes H; Rothenberg P; Scheers E; Mamidi RN
Clin Pharmacol Drug Dev; 2015 Jul; 4(4):295-304. PubMed ID: 27136910
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
Wenzler E; Ellis-Grosse EJ; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling.
Wen B; Zhang Y; Young GC; Kenworthy D; Pereira A; Pirhalla J; Doyle J; Jordon B; Zhan J; Johnson M
Drug Metab Dispos; 2022 Nov; 50(11):1442-1453. PubMed ID: 36153007
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
Nave R; Bethke TD; van Marle SP; Zech K
Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
[TBL] [Abstract][Full Text] [Related]
19. A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.
Mariotti F; Ciurlia G; Spaccapelo L; Muraro A; Acerbi D
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):269-279. PubMed ID: 27209586
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Biotransformation, and Excretion of [
Subramanian R; Zhu X; Hock MB; Sloey BJ; Wu B; Wilson SF; Egbuna O; Slatter JG; Xiao J; Skiles GL
Clin Pharmacokinet; 2017 Feb; 56(2):179-192. PubMed ID: 27517676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
